Proscia Appoints Dr. Monica Santamaria-Fries as Digital Transformation Officer to Guide Laboratories Amid Surge in Digital Pathology Adoption
Summary
At Proscia, Dr. Santamaria-Fries will act as the change agent for diagnostic laboratories making the transformation to digital pathology, ensuring that they are prepared to rapidly capitalize on its growing potential with an approach that evolves with their needs. In addition, Dr. Santamaria-Fries will work closely with Proscia’s commercial, regulatory, scientific, and technology teams to shape the company’s product roadmap and communicate clinical evidence. In April, the company announced that its Concentriq Dx digital pathology platform is now available for remote use in clinical practice in the United States during the COVID-19 public health emergency in response to guidance from the FDA. With the company’s Concentriq digital pathology platform and pipeline of AI-powered applications, laboratories are leveraging new kinds of data to accelerate discoveries and improve patient outcomes. Proscia’s team of technologists, scientists, and pathologists is bringing a fresh approach to an outdated industry, helping the world to keep pace with the increasing demand for pathology services and fulfill the promise of precision diagnostics.